Are there any covenants or lock‑up periods associated with the securities purchase agreement that could affect future share sales or insider activity? | OCGN (Aug 08, 2025) | Candlesense

Are there any covenants or lock‑up periods associated with the securities purchase agreement that could affect future share sales or insider activity?

Short answer:

Based on the information disclosed in the press release, the securities purchase agreement does not contain any explicit covenants or lock‑up periods that would restrict the future sale of the shares or the trading activity of insiders.


Why the release suggests there are no such restrictions

Provision described in the release Effect on future sales / insider activity
Purchase price and size – 20 million shares of common stock at $1.00 per share and warrants for up to another 20 million shares. Simply defines the amount and price of the securities being sold; no mention of post‑sale restrictions.
Warrant terms – Exercise price $1.50, exercisable immediately, expires two years from issuance, callable when the VWAP exceeds $2.50 for at least five of a trailing 30‑day period. These are exercise and redemption features of the warrants. They do not impose a lock‑up on the underlying common shares; they only affect the company’s right to call the warrants under a specific price‑performance condition.
No other language – The release does not reference “lock‑up,” “restriction,” “stand‑still,” “selling‑restriction,” “insider‑trading covenant,” “registration rights,” “right of first refusal,” or any similar clause. In the absence of any such language, we must assume that the agreement does not contain a special, publicly‑disclosed lock‑up or covenant beyond the standard, routine provisions that are typical for a registered direct offering.

What could still be present (but is not disclosed)

  1. Standard “lock‑up” provisions that are common in many direct offerings (e.g., a 30‑day lock‑up on the securities sold to the placement agent or to the underwriters).

    Because the press release does not mention them, we cannot confirm their existence.

  2. Insider‑trading or “sell‑restriction” covenants that might apply to company officers, directors, or large shareholders.

    Again, no such covenants are referenced in the summary.

  3. Registration‑rights or “right‑of‑first‑refusal” clauses that could affect later secondary offerings.

    These are not indicated in the disclosed terms.

If any of these typical clauses were included, they would normally be detailed in the Form S‑1 or Form 8‑K filing that accompanies the offering, not in the brief news release. Analysts, investors, or insiders who need to be certain about any potential trading restrictions should therefore review the actual securities purchase agreement (or the SEC filing that contains it) for the full set of terms.


Practical implications for shareholders and insiders

Scenario Impact based on the disclosed terms
Immediate resale of the newly issued shares No explicit lock‑up prevents an insider or the investor (Janus Henderson) from selling the shares right away, subject only to any standard “short‑sale‑restriction” rules that apply to all listed securities.
Exercise of the warrants Warrants can be exercised immediately at $1.50 per share, and the underlying shares received from that exercise are not subject to a lock‑up.
Potential call of the warrants The company may call the warrants if the VWAP > $2.50 for ≥ 5 of a trailing 30‑day period. This call does not force the holder to sell the underlying common shares; it merely requires the holder to surrender the warrants (or convert them) at the call price.
Future secondary offerings Since no lock‑up is disclosed, the company could, in principle, issue additional shares or conduct follow‑on offerings without being constrained by a pre‑existing lock‑up tied to this transaction.

Bottom line

  • No lock‑up or covenant is mentioned in the press release.
  • The only conditional feature is the callability of the warrants based on the stock’s VWAP, which does not restrict the sale of the common shares themselves.
  • For absolute certainty, interested parties should examine the SEC filing (e.g., Form 8‑K, Form S‑1, or the actual securities purchase agreement) where any undisclosed covenants would be listed.

Therefore, based solely on the information provided, there are no covenants or lock‑up periods that would affect future share sales or insider activity.